IL156695A0 - Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents - Google Patents

Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents

Info

Publication number
IL156695A0
IL156695A0 IL15669503A IL15669503A IL156695A0 IL 156695 A0 IL156695 A0 IL 156695A0 IL 15669503 A IL15669503 A IL 15669503A IL 15669503 A IL15669503 A IL 15669503A IL 156695 A0 IL156695 A0 IL 156695A0
Authority
IL
Israel
Prior art keywords
hemostatic
wound dressing
modified polysaccharide
containing aldehyde
dressing containing
Prior art date
Application number
IL15669503A
Other languages
English (en)
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of IL156695A0 publication Critical patent/IL156695A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15669503A 2002-11-26 2003-06-29 Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents IL156695A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/304,472 US20040101546A1 (en) 2002-11-26 2002-11-26 Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents

Publications (1)

Publication Number Publication Date
IL156695A0 true IL156695A0 (en) 2004-01-04

Family

ID=32298033

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15669503A IL156695A0 (en) 2002-11-26 2003-06-29 Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents

Country Status (11)

Country Link
US (2) US20040101546A1 (es)
EP (1) EP1424086A1 (es)
JP (1) JP2004174223A (es)
KR (1) KR20040047538A (es)
CN (1) CN1502375A (es)
AR (1) AR040305A1 (es)
AU (1) AU2003205012A1 (es)
BR (1) BR0304168A (es)
CA (1) CA2433961A1 (es)
IL (1) IL156695A0 (es)
TW (1) TW200408415A (es)

Families Citing this family (166)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1617800A (en) * 1998-11-12 2000-05-29 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
US20040106344A1 (en) * 2002-06-28 2004-06-03 Looney Dwayne Lee Hemostatic wound dressings containing proteinaceous polymers
RU2329274C2 (ru) 2002-09-11 2008-07-20 Фрезениус Каби Дойчланд Гмбх Способ получения производных гидроксиалкилкрахмала
ES2314238T3 (es) 2002-10-08 2009-03-16 Fresenius Kabi Deutschland Gmbh Conjugados de oligosacaridos farmaceuticamente activos.
AU2003302906B2 (en) * 2002-12-11 2009-04-02 Ferrosan Medical Devices A/S Gelatine-based materials as swabs
US20040265371A1 (en) * 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
WO2005027834A2 (en) * 2003-09-12 2005-03-31 Z-Medica Corporation Partially hydrated hemostatic agent
US7109163B2 (en) * 2004-01-30 2006-09-19 Ethicon, Inc. Hemostatic compositions and devices
AR054637A1 (es) * 2004-01-30 2007-07-11 Ferrosan As Aerosoles y composiciones hemostaticas
TWI417303B (zh) 2004-03-11 2013-12-01 Fresenius Kabi De Gmbh 經由還原胺化作用製得之羥烷基澱粉及蛋白質的接合物
US8021684B2 (en) * 2004-07-09 2011-09-20 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
US20060093655A1 (en) * 2004-10-20 2006-05-04 Lillian Bar Method for making a reinforced absorbable multilayered hemostatic wound dressing
US20060257457A1 (en) * 2004-10-20 2006-11-16 Gorman Anne J Method for making a reinforced absorbable multilayered hemostatic wound dressing
US20060258995A1 (en) * 2004-10-20 2006-11-16 Pendharkar Sanyog M Method for making a reinforced absorbable multilayered fabric for use in medical devices
JP5058808B2 (ja) * 2004-10-20 2012-10-24 エシコン・インコーポレイテッド 医療器具用の強化された吸収性複層布およびその製造方法
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
US20060178609A1 (en) * 2005-02-09 2006-08-10 Z-Medica, Llc Devices and methods for the delivery of molecular sieve materials for the formation of blood clots
WO2006088912A2 (en) 2005-02-15 2006-08-24 Virginia Commonwealth University Mineral technologies (mt) for acute hemostasis and for the treatment of acute wounds and chronic ulcers
US20070104768A1 (en) * 2005-11-07 2007-05-10 Z-Medica Corporation Devices for the delivery of molecular sieve materials for the formation of blood clots
US8277837B2 (en) 2006-01-11 2012-10-02 Entegrion, Inc. Hemostatic textile
US7854923B2 (en) * 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
US8938898B2 (en) * 2006-04-27 2015-01-27 Z-Medica, Llc Devices for the identification of medical products
US7604819B2 (en) 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US8202532B2 (en) * 2006-05-26 2012-06-19 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7968114B2 (en) * 2006-05-26 2011-06-28 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
IL178867A (en) * 2006-10-26 2010-05-31 Vladimir N Filatov Hemostatic textile material
US20080138387A1 (en) * 2006-12-07 2008-06-12 Machiraju Venkat R Hemostatic sponge and article
WO2008081463A2 (en) * 2007-01-04 2008-07-10 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
US7919480B2 (en) 2007-05-03 2011-04-05 Ethicon, Inc. Polymers having covalently bound antibiotic agents
WO2008157536A2 (en) * 2007-06-21 2008-12-24 Z-Medica Corporation Hemostatic sponge and method of making the same
US8932619B2 (en) * 2007-06-27 2015-01-13 Sofradim Production Dural repair material
US20090162406A1 (en) * 2007-09-05 2009-06-25 Z-Medica Corporation Wound healing with zeolite-based hemostatic devices
US20090068250A1 (en) * 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
US9308068B2 (en) 2007-12-03 2016-04-12 Sofradim Production Implant for parastomal hernia
EP2070950A1 (en) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkyl starch derivatives and process for their preparation
US8299316B2 (en) 2007-12-18 2012-10-30 Ethicon, Inc. Hemostatic device
US8642831B2 (en) * 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9242026B2 (en) 2008-06-27 2016-01-26 Sofradim Production Biosynthetic implant for soft tissue repair
US9271706B2 (en) * 2008-08-12 2016-03-01 Covidien Lp Medical device for wound closure and method of use
US9889230B2 (en) * 2008-10-17 2018-02-13 Covidien Lp Hemostatic implant
AR081227A1 (es) 2008-12-11 2012-07-18 Baxter Int Preparaciones basadas en fibrinogenos y polisacaridos sulfatados
WO2010102156A1 (en) * 2009-03-04 2010-09-10 Aaren Scientific Inc. System for characterizing a cornea and obtaining an ophthalmic lens
US8292952B2 (en) * 2009-03-04 2012-10-23 Aaren Scientific Inc. System for forming and modifying lenses and lenses formed thereby
US8646916B2 (en) * 2009-03-04 2014-02-11 Perfect Ip, Llc System for characterizing a cornea and obtaining an opthalmic lens
CA2949518C (en) 2009-05-28 2019-01-08 Gp Cellulose Gmbh Modified cellulose from chemical kraft fiber and methods of making and using the same
US9512237B2 (en) 2009-05-28 2016-12-06 Gp Cellulose Gmbh Method for inhibiting the growth of microbes with a modified cellulose fiber
US9512563B2 (en) 2009-05-28 2016-12-06 Gp Cellulose Gmbh Surface treated modified cellulose from chemical kraft fiber and methods of making and using same
US9511167B2 (en) 2009-05-28 2016-12-06 Gp Cellulose Gmbh Modified cellulose from chemical kraft fiber and methods of making and using the same
US20100318120A1 (en) * 2009-06-15 2010-12-16 John Howard Gordon Hemostatic material and delivery device
FR2949688B1 (fr) 2009-09-04 2012-08-24 Sofradim Production Tissu avec picots revetu d'une couche microporeuse bioresorbable
US8470355B2 (en) * 2009-10-01 2013-06-25 Covidien Lp Mesh implant
CN101693122B (zh) * 2009-10-22 2012-12-12 浙江大学 一种可降解高分子皮肤敷料的制备方法及应用
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
CZ2009836A3 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
US20110152924A1 (en) * 2009-12-22 2011-06-23 Michel Gensini Oxidized regenerated cellulose adhesive tape
GB201012333D0 (en) * 2010-07-22 2010-09-08 Convatec Technologies Inc Fibres, a process for producing such fibres and a wound dressing incorporating them
US8858969B2 (en) 2010-09-22 2014-10-14 Z-Medica, Llc Hemostatic compositions, devices, and methods
JP6000259B2 (ja) * 2010-10-06 2016-09-28 メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ 止血障害治療用第ｉｉ因子およびフィブリノーゲン
US9084602B2 (en) 2011-01-26 2015-07-21 Covidien Lp Buttress film with hemostatic action for surgical stapling apparatus
FR2972626B1 (fr) 2011-03-16 2014-04-11 Sofradim Production Prothese comprenant un tricot tridimensionnel et ajoure
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
AU2012268700B2 (en) 2011-05-23 2017-02-02 Gp Cellulose Gmbh Softwood kraft fiber having improved whiteness and brightness and methods of making and using the same
FR2977790B1 (fr) 2011-07-13 2013-07-19 Sofradim Production Prothese pour hernie ombilicale
FR2977789B1 (fr) 2011-07-13 2013-07-19 Sofradim Production Prothese pour hernie ombilicale
WO2013020094A2 (en) * 2011-08-03 2013-02-07 Avant Garde Therapeutics Inc. Novel hemostatic patch and uses thereof
WO2013046057A1 (en) 2011-09-30 2013-04-04 Sofradim Production Multilayer implants for delivery of therapeutic agents
EP2760494B1 (en) 2011-09-30 2017-04-19 Sofradim Production Reversible stiffening of light weight mesh
FR2985271B1 (fr) 2011-12-29 2014-01-24 Sofradim Production Tricot a picots
FR2985170B1 (fr) 2011-12-29 2014-01-24 Sofradim Production Prothese pour hernie inguinale
TWI628331B (zh) 2012-01-12 2018-07-01 Ｇｐ纖維股份有限公司 具有降低黃化性質之低黏度牛皮紙纖維及其製造與使用方法
GB201201751D0 (en) * 2012-02-01 2012-03-14 Haemostatix Ltd Haemostatic wound dressing
CZ2012136A3 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP3495550A1 (en) 2012-04-18 2019-06-12 GP Cellulose GmbH The use of surfactant to treat pulp and improve the incorporation of kraft pulp into fiber for the production of viscose and other secondary fiber products
AR091031A1 (es) 2012-05-14 2014-12-30 Teijin Ltd Producto en planchas y material hemostatico
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
KR102375103B1 (ko) 2012-06-22 2022-03-16 지-메디카 엘엘씨 지혈 장치
EP3276350B1 (en) * 2012-06-22 2020-08-05 Bio-Rad Laboratories, Inc. Human factor xiii as a normalization control for immunoassays
FR2994185B1 (fr) 2012-08-02 2015-07-31 Sofradim Production Procede de preparation d’une couche poreuse a base de chitosane
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
FR2995788B1 (fr) 2012-09-25 2014-09-26 Sofradim Production Patch hemostatique et procede de preparation
FR2995778B1 (fr) 2012-09-25 2015-06-26 Sofradim Production Prothese de renfort de la paroi abdominale et procede de fabrication
FR2995779B1 (fr) 2012-09-25 2015-09-25 Sofradim Production Prothese comprenant un treillis et un moyen de consolidation
CA2880380C (en) 2012-09-28 2020-09-15 Sofradim Production Packaging for a hernia repair device
CZ2012842A3 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
CZ304266B6 (cs) 2012-11-27 2014-02-05 Contipro Biotech S.R.O. Nekonečná vlákna na bázi hyaluronanu selektivně oxidovaného v poloze 6 N-acetyl-D-glukosaminové části, jejich příprava, použití, nitě, střiže, příze, textilie a způsob jejich úpravy
WO2014122533A2 (en) 2013-02-08 2014-08-14 Gp Cellulose Gmbh Softwood kraft fiber having an improved a-cellulose content and its use in the production of chemical cellulose products
RU2671653C2 (ru) 2013-03-14 2018-11-06 ДжиПи СЕЛЛЬЮЛОУС ГМБХ Способ изготовления высокофункционального маловязкого крафтволокна с использованием последовательности кислотного отбеливания и волокно, изготовленное с помощью этого процесса
CN105143547B (zh) 2013-03-15 2018-05-01 Gp 纤维素股份有限公司 具有增高羧基含量的低粘度牛皮纸纤维及其制造和使用方法
CN103230617B (zh) * 2013-04-24 2015-02-04 四川大学 一种胶原/壳聚糖微纳纤维复合止血膜材料及其制备方法
CN103263687B (zh) * 2013-06-07 2014-07-30 南京美纯生物科技有限公司 一种生物型敷料贴
FR3006581B1 (fr) 2013-06-07 2016-07-22 Sofradim Production Prothese a base d’un textile pour voie laparoscopique
FR3006578B1 (fr) 2013-06-07 2015-05-29 Sofradim Production Prothese a base d’un textile pour voie laparoscopique
BR112015030612B1 (pt) 2013-06-21 2020-07-21 Ferrosan Medical Devices A/S método para preparar uma composição seca
IL229645A0 (en) * 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin
EP3470094B1 (en) 2013-12-11 2020-07-22 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CZ305153B6 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
EP3000489B1 (en) 2014-09-24 2017-04-05 Sofradim Production Method for preparing an anti-adhesion barrier film
CN104288826A (zh) * 2014-09-26 2015-01-21 张明 一种医用壳聚糖快速止血敷料
EP3000433B1 (en) 2014-09-29 2022-09-21 Sofradim Production Device for introducing a prosthesis for hernia treatment into an incision and flexible textile based prosthesis
EP3000432B1 (en) 2014-09-29 2022-05-04 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
CN104524620B (zh) * 2014-11-25 2017-03-15 深圳市海琪时代实业有限公司 一种改性复合海绵敷料及其制备方法
EP3029189B1 (en) 2014-12-05 2021-08-11 Sofradim Production Prosthetic porous knit, method of making same and hernia prosthesis
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
EP3059255B1 (en) 2015-02-17 2020-05-13 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US11382731B2 (en) 2015-02-27 2022-07-12 Covidien Lp Medical devices with sealing properties
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
EP3085337B1 (en) 2015-04-24 2022-09-14 Sofradim Production Prosthesis for supporting a breast structure
GB201508024D0 (en) 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions
CZ306479B6 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
EP3106185B1 (en) 2015-06-19 2018-04-25 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CN107771093B (zh) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 用于混合两种组分和用于在存储条件下保持真空的注射器
KR20170007024A (ko) * 2015-07-10 2017-01-18 (주)헵틸와이 이중 가교구조의 생체친화성 지혈제 및 그 제조방법
CN105126153B (zh) * 2015-08-27 2018-07-31 北京大清生物技术股份有限公司 一种含有凝血酶的复合止血膜及其制备方法
CN105233328A (zh) * 2015-10-23 2016-01-13 徐爱军 能促进手术刀口快速愈合的医用无纺布敷料
US10034957B2 (en) * 2015-11-06 2018-07-31 Ethicon Llc Compacted hemostatic cellulosic aggregates
CN105477679B (zh) * 2015-11-30 2018-07-27 北京化工大学 基于多糖交联的壳聚糖快速止血棉
EP3195830B1 (en) 2016-01-25 2020-11-18 Sofradim Production Prosthesis for hernia repair
CN105797211A (zh) * 2016-03-31 2016-07-27 宁波国际材料基因工程研究院有限公司 水凝胶的制备方法、含成骨细胞水凝胶及其制备方法
CN105641735B (zh) * 2016-04-07 2018-09-21 北京化工大学 一种抗菌性多糖止血棉基纱布的制备方法
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
CN106178089A (zh) * 2016-07-21 2016-12-07 青岛中腾生物技术有限公司 一种医用韧性封闭止血材料及组合物
US11413335B2 (en) 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
CN106344960B (zh) * 2016-09-20 2019-02-22 安徽思维特生物科技有限公司 利用微晶纤维素接枝改性胎牛皮胶原纤维制备的止血凝胶
EP3312325B1 (en) 2016-10-21 2021-09-22 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
CA3040734A1 (en) 2016-11-16 2018-05-24 Gp Cellulose Gmbh Modified cellulose from chemical fiber and methods of making and using the same
EP3398554A1 (en) 2017-05-02 2018-11-07 Sofradim Production Prosthesis for inguinal hernia repair
CN107349459B (zh) * 2017-06-16 2019-11-26 大连理工大学 一种葡聚糖基止血抗菌促愈合材料及其制备方法
CN108187131A (zh) * 2017-12-29 2018-06-22 孙祎 一种医用抗菌水胶体敷料的制备方法
EP3737432B1 (en) * 2018-01-12 2022-12-28 Boston Scientific Scimed Inc. Powder for achieving hemostasis
CN108478846A (zh) * 2018-04-20 2018-09-04 薛春玲 一种医用止血抗菌敷料及其制备方法
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
CN109106977B (zh) * 2018-08-27 2021-06-11 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 一种用于糖尿病创面修复的自愈合可注射水凝胶敷料及其制备方法与应用
CN109453417A (zh) * 2018-10-08 2019-03-12 中国海洋大学 一种多糖烧伤敷料及其制备方法和应用
EP3653171B1 (en) 2018-11-16 2024-08-21 Sofradim Production Implants suitable for soft tissue repair
US10517988B1 (en) 2018-11-19 2019-12-31 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation
EP4403194A2 (en) 2018-11-19 2024-07-24 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation
CN109481148B (zh) * 2018-12-24 2019-08-16 苏州榭睿迦医疗科技发展有限公司 一种吸湿透气型伤口敷料贴
US20220120769A1 (en) * 2019-02-14 2022-04-21 Nc Bit Inc. Hemostatic Enzyme and Carboxymethyl Chitosan-Containing Composition for Blood Coagulation Test, and Use Thereof
CN110575562B (zh) * 2019-10-15 2023-08-08 华东理工大学 一种具有时序止血作用的淀粉基止血材料及其制备方法
CN110975001B (zh) * 2019-12-09 2022-04-12 军事科学院系统工程研究院卫勤保障技术研究所 壳聚糖-纤维素复合止血海绵及制备方法和应用
US12064330B2 (en) 2020-04-28 2024-08-20 Covidien Lp Implantable prothesis for minimally invasive hernia repair
CN112870430B (zh) * 2021-02-02 2022-02-01 四川大学 基于天然多糖的复合凝胶止血粉、其制备方法及应用
US11849950B2 (en) * 2021-03-30 2023-12-26 Cilag Gmbh International Compressible adjuncts with drug dosage control features
US11839374B2 (en) 2021-03-30 2023-12-12 Cilag Gmbh International Compressible adjuncts with drug release features
US11864765B2 (en) 2021-03-30 2024-01-09 Cilag Gmbh International Compressible adjuncts with fluid control features
US11627961B2 (en) 2021-03-30 2023-04-18 Cilag Gmbh International Compressible adjuncts with different behavioral zones
US11602341B2 (en) 2021-03-30 2023-03-14 Cilag Gmbh International Compressible adjuncts with drug release features
US12059153B2 (en) 2021-03-30 2024-08-13 Cilag Gmbh International Implantable adjuncts having adjustable degradation profile
US11786240B2 (en) 2021-03-30 2023-10-17 Cilag Gmbh International Using smart packaging in adjusting use of tissue adjuncts
US11850332B2 (en) 2021-03-30 2023-12-26 Cilag Gmbh International Method for treating tissue
US11896226B2 (en) 2021-03-30 2024-02-13 Cilag Gmbh International Compressible adjuncts with healing-dependent degradation profile
CN113855852B (zh) * 2021-09-28 2022-06-28 蓝科医美科学技术(吉林)有限公司 一种含有人参提取物的修复敷料及其制备方法
CN114163540B (zh) * 2021-12-09 2022-10-21 中国海洋大学 一种双功能化细菌纤维素复合物、制备方法及其应用
CN115475271B (zh) * 2022-08-19 2023-11-24 上海纳米技术及应用国家工程研究中心有限公司 一种氨基酸/稀土纳米晶/纳米纤维素抗菌止血敷料的制备方法
CN117899257A (zh) * 2024-01-12 2024-04-19 海宁侏罗纪生物科技有限公司 一种多糖粉末粘合止血材料及其制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517772A (en) * 1945-05-11 1950-08-08 Parke Davis & Co Neutralized oxidized cellulose products
US2914444A (en) * 1950-12-12 1959-11-24 David F Smith Cellulosic hemostatic composition
US2773000A (en) * 1952-06-06 1956-12-04 Johnson & Johnson Hemostatic surgical dressings
US3364200A (en) * 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US3328259A (en) * 1964-01-08 1967-06-27 Parachem Corp Dressing for a wound containing a hemostatic agent and method of treating a wound
US3868955A (en) * 1973-10-05 1975-03-04 Personal Products Co Aldehyde polysaccharide dressings
US4289824A (en) * 1977-04-22 1981-09-15 Avtex Fibers Inc. High fluid-holding alloy rayon fiber mass
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
DE3037513C2 (de) * 1980-10-03 1983-05-05 Steffan, Wolfgang, 8425 Neustadt Kollagene Wundauflage
US4600574A (en) * 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
US4626253A (en) * 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
US5002551A (en) * 1985-08-22 1991-03-26 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
US20020192271A1 (en) * 1985-11-26 2002-12-19 Hedner Ulla Karin Elisabeth Method for causing local hemostasis and hemostatic composition for local hemostasis
US4840626A (en) * 1986-09-29 1989-06-20 Johnson & Johnson Patient Care, Inc. Heparin-containing adhesion prevention barrier and process
US4752466A (en) * 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US5134229A (en) * 1990-01-12 1992-07-28 Johnson & Johnson Medical, Inc. Process for preparing a neutralized oxidized cellulose product and its method of use
US5180398A (en) * 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
ATE273035T1 (de) * 1993-11-03 2004-08-15 Clarion Pharmaceuticals Inc Hämostatisches pflaster
JP2791317B2 (ja) * 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
US5925552A (en) * 1996-04-25 1999-07-20 Medtronic, Inc. Method for attachment of biomolecules to medical devices surfaces
US5945319A (en) * 1996-04-25 1999-08-31 Medtronic, Inc. Periodate oxidative method for attachment of biomolecules to medical device surfaces
US5821343A (en) * 1996-04-25 1998-10-13 Medtronic Inc Oxidative method for attachment of biomolecules to surfaces of medical devices
GB2314842B (en) * 1996-06-28 2001-01-17 Johnson & Johnson Medical Collagen-oxidized regenerated cellulose complexes
US6500777B1 (en) * 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
US6706690B2 (en) * 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
ZA987019B (en) * 1997-08-06 1999-06-04 Focal Inc Hemostatic tissue sealants
JP3114016B2 (ja) * 1998-05-15 2000-12-04 株式会社ホギメディカル 細胞接着促進効果を有する創傷止血材
US6261679B1 (en) * 1998-05-22 2001-07-17 Kimberly-Clark Worldwide, Inc. Fibrous absorbent material and methods of making the same
DE19851334C2 (de) * 1998-11-06 2000-09-28 Aventis Behring Gmbh Flexible Wundauflage auf Fibrinbasis und Verfahren zu ihrer Herstellung
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US6306424B1 (en) * 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
US6627785B1 (en) * 2000-02-29 2003-09-30 Virginia Commwealth University Wound dressings with protease-lowering activity
EP1299135B1 (en) * 2000-07-04 2006-09-20 Frohwitter, Bernhard Wound dressing comprising terrilytin as therapeutically active agent
US6963535B2 (en) * 2000-12-28 2005-11-08 Intel Corporation MAC bus interface
US6923961B2 (en) * 2002-04-30 2005-08-02 Fziomed, Inc. Chemically activated carboxypolysaccharides and methods for use to inhibit adhesion formation and promote hemostasis
US7252837B2 (en) * 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US20040120993A1 (en) * 2002-12-20 2004-06-24 Guanghui Zhang Hemostatic wound dressing and fabric and methods of making and using same
US7279177B2 (en) * 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US20040106344A1 (en) * 2002-06-28 2004-06-03 Looney Dwayne Lee Hemostatic wound dressings containing proteinaceous polymers
US7019191B2 (en) * 2003-03-25 2006-03-28 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US20040241212A1 (en) * 2003-05-30 2004-12-02 Pendharkar Sanyog Manohar Biodegradable hemostatic wound dressings
US20040265371A1 (en) * 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same

Also Published As

Publication number Publication date
US20060159733A1 (en) 2006-07-20
CA2433961A1 (en) 2004-05-26
AR040305A1 (es) 2005-03-23
AU2003205012A1 (en) 2004-06-17
TW200408415A (en) 2004-06-01
KR20040047538A (ko) 2004-06-05
JP2004174223A (ja) 2004-06-24
US20040101546A1 (en) 2004-05-27
EP1424086A1 (en) 2004-06-02
CN1502375A (zh) 2004-06-09
BR0304168A (pt) 2004-08-31

Similar Documents

Publication Publication Date Title
IL156695A0 (en) Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
IL156697A0 (en) Hemostatic wound dressing containing aldehyde-modified polysaccharide
IL156676A0 (en) Hemostatic wound dressings and methods of making same
EP1423515A4 (en) COMPOUNDS AGAINST AGING AND WOUND HEALING
EP1555980A4 (en) MEDICAL ASSOCIATION WITH AN ANTIMICROBIAL MEDIUM
AU2002327666A1 (en) Adhesive bandage containing an antimicrobial and an hemostatic agent
AU2003294367A8 (en) Wound dressing
AU151743S (en) Wound dressing
IL156681A0 (en) Hemostatic wound dressing and fabric and methods of making and using same
GB0215023D0 (en) Wound dressing
IL156696A0 (en) Wound dressing containing aldehyde-modified regenerated polysaccharide
AU2003250540A1 (en) Retarder and circular polarizer
AU2003229902A1 (en) Apertured hydrogel wound dressing
AU2003275268A8 (en) Hemostatic compositions and methods
AU2002365398A1 (en) Flexible and absorbent alginate wound dressing
AU2002351292A8 (en) Hemostatic agent delivery system
AU2003291456A8 (en) Methods for promoting wound healing and uses thereof
AU2003299660A1 (en) Wound and skin care compositions
GB0201385D0 (en) Particulate wound dressings
EP1496825A4 (en) CONDUCTIVE WOUND DRESSINGS AND METHODS OF USE
GB2395906B (en) Wound dressings containing an enzyme therapeutic agent
GB0107655D0 (en) Wound dressing
AU2002241628A1 (en) Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
AU2003235547A1 (en) Hemostatic dressing
AU2003257089A1 (en) Antimicrobial and antiproteolytic wound dressing